BioInvent International Aktiebolag
556537-7263ActiveClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Oversigt
- 100–199
- Medarbejdere
- 20–50mio SEK
- Omsætning
- 1997
- Grundlagt
Nøglebeslutningstagere
Cecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Anette Mårtensson
Employee deputy, Member of the Board
Emma Meurling
HR Director
+19 flere kontakter i Funnelfeedr
Beskrivelse
BioInvent is a clinical-stage biotechnology company focused on discovering and developing innovative antibody therapeutics for cancer treatment. The core of their work lies in leveraging deep expertise in immunology, cancer biology, and antibody biology to generate novel immuno-oncology drug candida...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556537726301
Beslutningstagere
23 kontakter i FunnelfeedrCecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Anette Mårtensson
Employee deputy, Member of the Board
Emma Meurling
HR Director
Nanna Lüneborg
Member of the Board
Andres McAllister
Chief Medical Officer
Kristoffer Bissessar
Member of the Board
Björn Frendéus
CSO
Leonard Kruimer
Chairman of the Board
Martin Welschof
Chief Executive Officer
Kristoffer Rudenholm Hansson
Senior Vice President, Technical Operations
Natalie Berner
Member of the Board
Vincent Ossipow
Member of the Board
Laura Lassouw-Polman
Member of the Board
Bernd Seizinger
Member of the Board
Sylvie Ryckebusch
Chief Business Officer
Stefan Ericsson
Chief Financial Officer
Ashley Robinson
Senior Vice President Strategy & Finance
Ingunn Munch Lindvig
Senior Vice President Regulatory Affairs
Andre kontakter
Marina Mangold
Data Protection Officer
Mona Welschof
Clinical Operations
Tomas Wall
Employee Representative
Elin Birgersson
Employee Representative
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrAlligator Bioscience AB
10–19 medarbejdereClinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
CAEDO ONCOLOGY AS
Developing novel monoclonal antibodies for targeted cancer immunotherapy treatment.
Active Biotech AB (publ)
1–4 medarbejdereDeveloping novel treatments for cancer and inflammatory eye diseases.
Affibody AB
50–99 medarbejdereDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Respiratorius AB (publ)
Developing novel drugs to treat aggressive lymphoma cancers.
Udforsk mere
Spørgsmål om BioInvent International Aktiebolag
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo